High In-hospital glycemic variability Independent Predictor of 1-yr Mortality in Acute HF Patients

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2023-01-04 03:30 GMT | Update On 2023-01-04 07:07 GMT

High In-hospital glycemic variability (GV) is an Independent Predictor of 1-yr Mortality in Acute HF Patients suggests a recent study published in the Cardiovascular Diabetology.

High glycemic variability (GV) is a poor prognostic marker in cardiovascular diseases. We aimed to investigate the association of GV with all-cause mortality in patients with acute heart failure (HF).

The Korean Acute Heart Failure registry enrolled patients hospitalized for acute HF from 2011 to 2014. Blood glucose levels were measured at the time of admission, during hospitalization, and at discharge. They included those who had 3 or more blood glucose measurements in this study. Patients were divided into two groups based on the coefficient of variation (CoV) as an indicator of GV. Among survivors of the index hospitalization, we investigated all-cause mortality at 1 year after discharge.

Results

• The study analyzed 2,617 patients (median age, 72 years; median left-ventricular ejection fraction, 36%; 53% male).

• During the median follow-up period of 11 months, 583 patients died. Kaplan–Meier curve analysis revealed that high GV (CoV > 21%) was associated with lower cumulative survival

• Multivariate Cox proportional analysis showed that high GV was associated with an increased risk of 1-year mortality.

• High GV significantly increased the risk of 1-year mortality in non-diabetic patients but not in diabetic patients

• High in-hospital GV before discharge was associated with all-cause mortality within 1 year, especially in non-diabetic patients with acute HF.

Reference:

Chun, KH., Oh, J., Lee, C.J. et al. In-hospital glycemic variability and all-cause mortality among patients hospitalized for acute heart failure. Cardiovasc Diabetol 21, 291 (2022). https://doi.org/10.1186/s12933-022-01720-4

Keywords:

Glucose metabolism disorder, Glycemic variability, Type 2 diabetes mellitus, Heart failure, Cardiovascular Diabetology, Chun, KH., Oh, J., Lee, C.J.

Article Source : Cardiovascular Diabetology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Dr. Shravani Dali

Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

High In-hospital glycemic variability Independent Predictor of 1-yr Mortality in Acute HF Patients

Similar News

FDA Approves Inclisiran as First-Line LDL-C Treatment Without Statins

Prepregnancy cardiovascular risk factor clusters increased the risk of stillbirth: JAHA

One Diet, Dual Benefits: DASH4D Lowers Blood Sugar and Blood Pressure, Study Shows

Dapagliflozin Improves Heart Structure in HFpEF Patients with Type 2 Diabetes:Study

Chronic Inflammation May Link Frailty, Social Disadvantage, and Heart Disease: Study Finds

Research Highlights Simple Lifestyle Habit That May Lower Blood Pressure After Menopause

Flu Vaccination May Cut Stroke Risk by Over 70 Percent in Elderly With Chronic Conditions: Study

Poststroke Depression Persists or Recurs in Majority of Affected Patients Over 5 Years: Study Finds